Allergan Finance, LLC Sustainability Profile
Allergan Finance, LLC, a prominent player in the pharmaceutical and biotechnology industry, is headquartered in the United States. Founded in 1983, the company has established itself as a leader in the development of innovative medical aesthetics, eye care, and neuroscience products. With a strong presence in North America and Europe, Allergan Finance is renowned for its flagship offerings, including the popular Botox® treatment and a range of dermal fillers. The company has achieved significant milestones, including its acquisition by AbbVie in 2020, which further solidified its market position. Allergan Finance is committed to advancing healthcare solutions that enhance patient outcomes, making it a trusted name in the industry. Its unique focus on both aesthetic and therapeutic applications sets it apart, ensuring a diverse portfolio that meets the evolving needs of healthcare professionals and patients alike.
DitchCarbon Score
How does Allergan Finance, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Allergan Finance, LLC's score of 65 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Allergan Finance, LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of AbbVie Inc., which influences its climate commitments and initiatives. While Allergan Finance, LLC does not have its own documented reduction targets, it inherits sustainability initiatives from AbbVie Inc. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions in line with climate science. As part of its corporate family relationship with AbbVie Inc., Allergan Finance, LLC aligns with broader industry standards and commitments to address climate change, although specific targets or achievements at the subsidiary level are not detailed. The company's climate strategy is likely informed by AbbVie’s overarching sustainability goals, which may include commitments to reduce Scope 1, 2, and 3 emissions, although specific figures and targets are not available for Allergan Finance, LLC itself. In summary, while Allergan Finance, LLC does not provide specific emissions data or reduction targets, it is part of a larger corporate structure that is actively engaged in climate initiatives through its parent company, AbbVie Inc.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 402,448,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | - | - | - |
How Carbon Intensive is Allergan Finance, LLC's Industry?
How Carbon Intensive is Allergan Finance, LLC's Location?
Allergan Finance, LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Allergan Finance, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
